Immunomedics preclinical data

In a mouse model of MCL, twice-weekly 370 µg 20-(74)-(74) for 2 weeks significantly increased median survival time vs. saline-treated controls (53 vs. 34 days). 20-(74)-(74) is a bispecific hexavalent...